Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
The 6000TOCi on-line TOC sensor delivers reliable data to demonstrate compliance in Pharmaceutical water systems.
read more
Thursday, October 01, 2026
53Biologics is investing more than €2 million to add freeze-drying equipment at its manufacturing site in Boecillo, Spain. The expansion will allow the contract developer and manufacturer to offer an additional fill-and-finish step for biologic ...
read more
Wednesday, December 01, 2021
AGC Biologics, a global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced a new partnership with 4TEEN4 Pharmaceuticals GmbH to manufacture and commercialize Procizumab. The first-in-class monoclonal antibody ...
read more
Tuesday, October 22, 2019
4G Clinical announced its recognition as the BSMA Supply Chain Management Excellence and Innovation Award 2019 recipient for its utilization of NLP to turn study parameters into detailed forecasts.
read more
4G Clinical, a cutting-edge randomization and trial supply management (RTSM) company, entered an agreement to receive a growth equity investment of over $230M from Goldman Sachs. The investment will be used to fund 4G Clinical's continued global ...
read more
Monday, September 28, 2026
4basebio and TriLink BioTechnologies will provide DNA starting material and mRNA manufacturing services for an unnamed multinational pharmaceutical company’s planned Phase 1 cell therapy trial.
read more
Thursday, August 27, 2026
4basebio and Genezen have expanded a non-exclusive collaboration intended to give cell and gene therapy developers access to synthetic, cell-free DNA for viral vector development and clinical programs.
read more
Medical device manufacturers hoping to enter the US market face increasing commercial competition and challenges to gain the funding necessary to support emerging brands. Because development and commercialization can consume a lot of resources, many...
read more
What key topics will be discussed at the 3rd Anti-Counterfeiting for Pharmaceuticals?
read more
Friday, September 20, 2019
The FDA has classified 3P facilities as acceptable for the manufacture of the target molecule, and appropriate for its commercialization in the US market, once the product is authorized.
read more
Thursday, December 27, 2018
3P Biopharmaceuticals has completed the project for the expansion and improvement of its facilities in Noáin (Spain) that had been carried out over the past months
read more
3P Biopharmaceuticals (3P) announced Keensight Capital as its new major investor.
read more
3P Biopharmaceuticals has signed a collaboration agreement with the Dutch biotech company Xenikos that will cover the global manufacturing of Xenikos’ proprietary lead product candidate T-Guard®.
read more
Monday, December 16, 2019
3M has entered into an agreement to sell substantially all of its drug delivery business to an affiliate of Altaris Capital Partners.
read more
3M Drug Delivery Systems U.K. organization is bringing its teams under one roof in Loughborough.
read more